Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. (“Merck” or the“Company”) (NYSE: MRK) and reminds investors of the April 14, ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

About Merck At Merck, known as MSD outside of the ... statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings ...

BELOW will present some of the brightest stars from Broadway, cabaret, jazz, and beyond, including Jenn Colella, and more.

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

February 19, 2025, the company was named an Advanced Partner under the X Ads Agency Certification Program by X Corp. Japan K.K. Among all certified advertising agencies, X Corp. Japan K.K. recognizes ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

As digital channels become the backbone for sharing information and facilitating school-to-home connections, Edlio, a leading provider of technology ...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...